Global Anti-Infective Drugs Market 2017 Share, Size, Forecast 2022

Published On: Oct 2017

Format: PDF

Publisher: QY Research

Pages: 117

Report ID: 123349

In this report, the global Anti-Infective Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Anti-Infective Drugs in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Anti-Infective Drugs market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Wyeth
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
MerLion Pharma
Theravance
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Antibiotic Drugs
Antiviral Drugs
Antifungal Drugs
Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Anti-Infective Drugs for each application, including
Hospital
Clinic
Home
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Anti-Infective Drugs Market Research Report 2017
1 Anti-Infective Drugs Market Overview
1.1 Product Overview and Scope of Anti-Infective Drugs
1.2 Anti-Infective Drugs Segment by Type (Product Category)
1.2.1 Global Anti-Infective Drugs Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Anti-Infective Drugs Production Market Share by Type (Product Category) in 2016
1.2.3 Antibiotic Drugs
1.2.4 Antiviral Drugs
1.2.5 Antifungal Drugs
1.2.6 Other
1.3 Global Anti-Infective Drugs Segment by Application
1.3.1 Anti-Infective Drugs Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home
1.3.5 Other
1.4 Global Anti-Infective Drugs Market by Region (2012-2022)
1.4.1 Global Anti-Infective Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Anti-Infective Drugs (2012-2022)
1.5.1 Global Anti-Infective Drugs Revenue Status and Outlook (2012-2022)
1.5.2 Global Anti-Infective Drugs Capacity, Production Status and Outlook (2012-2022)

2 Global Anti-Infective Drugs Market Competition by Manufacturers
2.1 Global Anti-Infective Drugs Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Anti-Infective Drugs Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Anti-Infective Drugs Production and Share by Manufacturers (2012-2017)
2.2 Global Anti-Infective Drugs Revenue and Share by Manufacturers (2012-2017)
2.3 Global Anti-Infective Drugs Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Anti-Infective Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti-Infective Drugs Market Competitive Situation and Trends
2.5.1 Anti-Infective Drugs Market Concentration Rate
2.5.2 Anti-Infective Drugs Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Infective Drugs Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Anti-Infective Drugs Capacity and Market Share by Region (2012-2017)
3.2 Global Anti-Infective Drugs Production and Market Share by Region (2012-2017)
3.3 Global Anti-Infective Drugs Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Anti-Infective Drugs Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Anti-Infective Drugs Consumption by Region (2012-2017)
4.2 North America Anti-Infective Drugs Production, Consumption, Export, Import (2012-2017)
4.3 Europe Anti-Infective Drugs Production, Consumption, Export, Import (2012-2017)
4.4 China Anti-Infective Drugs Production, Consumption, Export, Import (2012-2017)
4.5 Japan Anti-Infective Drugs Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Anti-Infective Drugs Production, Consumption, Export, Import (2012-2017)
4.7 India Anti-Infective Drugs Production, Consumption, Export, Import (2012-2017)

5 Global Anti-Infective Drugs Production, Revenue (Value), Price Trend by Type
5.1 Global Anti-Infective Drugs Production and Market Share by Type (2012-2017)
5.2 Global Anti-Infective Drugs Revenue and Market Share by Type (2012-2017)
5.3 Global Anti-Infective Drugs Price by Type (2012-2017)
5.4 Global Anti-Infective Drugs Production Growth by Type (2012-2017)

6 Global Anti-Infective Drugs Market Analysis by Application
6.1 Global Anti-Infective Drugs Consumption and Market Share by Application (2012-2017)
6.2 Global Anti-Infective Drugs Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Anti-Infective Drugs Manufacturers Profiles/Analysis
7.1 GlaxoSmithKline
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Anti-Infective Drugs Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 GlaxoSmithKline Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Merck
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Anti-Infective Drugs Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Merck Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Pfizer
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Anti-Infective Drugs Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Pfizer Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Novartis AG
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Anti-Infective Drugs Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Novartis AG Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Gilead Sciences
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Anti-Infective Drugs Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Gilead Sciences Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Abbott
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Anti-Infective Drugs Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Abbott Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Wyeth
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Anti-Infective Drugs Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Wyeth Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 Sanofi-Aventis
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Anti-Infective Drugs Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Sanofi-Aventis Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Bristol-Myers Squibb
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Anti-Infective Drugs Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Bristol-Myers Squibb Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Johnson
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Anti-Infective Drugs Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Johnson Anti-Infective Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Roche Pharma AG
7.12 Nanosphere
7.13 NanoViricides
7.14 Novabay Pharmaceuticals
7.15 Obetech
7.16 Optimer Pharmaceuticals
7.17 Basilea Pharmaceutica AG
7.18 Daiichi Sankyo
7.19 MerLion Pharma
7.20 Theravance

8 Anti-Infective Drugs Manufacturing Cost Analysis
8.1 Anti-Infective Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti-Infective Drugs

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Anti-Infective Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti-Infective Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Anti-Infective Drugs Market Forecast (2017-2022)
12.1 Global Anti-Infective Drugs Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Anti-Infective Drugs Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Anti-Infective Drugs Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Anti-Infective Drugs Price and Trend Forecast (2017-2022)
12.2 Global Anti-Infective Drugs Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Anti-Infective Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Anti-Infective Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Anti-Infective Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Anti-Infective Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Anti-Infective Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Anti-Infective Drugs Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Anti-Infective Drugs Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Anti-Infective Drugs Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer